Results 81 to 90 of about 75,218 (96)

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases. [PDF]

Nephrol Dial Transplant
Apperloo EM, Heerspink HJL, van Raalte DH, Muskiet MHA.   +3 more
europepmc   +1 more source

GLP-1 receptor agonists for obesity: eligibility across 99 countries. [PDF]

Lancet Diabetes Endocrinol
Yoo SGK, Teufel F, Theilmann M, Si Y, Toure EA, Aryal K, Bärnighausen T, Bait A, Barreto M, Bovet P, Brant LCC, Cuschieri S, Damasceno A, Farzadfar F, Fawwad A, Geldsetzer P, Hambleton IR, Houehanou C, Howitt C, J Rgensen J, González-Rivas JP, Labadarios D, Marcus M, Martins J, Mwalim O, Nieto-Martínez R, Odili AN, Orazumbekova B, Perman G, Quesnel-Crooks S, Moghaddam SS, Sewpal R, Sousa-Uva M, Sulola MA, Venkataraman K, Vollmer S, Xueling S, Atun R, Banegas JR, Franco JVA, Arnott C, Chandiwana N, Huffman MD, Davies J, Ali MK, Flood D, Manne-Goehler J.   +46 more
europepmc   +1 more source

Incidentalomas of the heart: lipomatous hypertrophy of the interatrial septum in the GLP-1 era. [PDF]

Ann Med Surg (Lond)
Khan MS, Ali RH, Imtiaz E, Ali FZ, Mahato RK.   +4 more
europepmc   +1 more source

GLP-1 agonists and exercise: the future of lifestyle prioritization. [PDF]

Front Clin Diabetes Healthc
Codella R, Senesi P, Luzi L.
europepmc   +1 more source

Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease. [PDF]

Int J Nephrol Renovasc Dis
Rajan K, Jutley AK, Holliday MW, Navaneethan SD.   +3 more
europepmc   +1 more source

Negative Consequences of Removing GLP-1 RA Obesity Coverage: A Cross-Sectional Cohort Comparison Study. [PDF]

Obes Sci Pract
Francis JM, Ernest DK, Chandrasekhar A, Herrington G, Gazda C, Xie L, Mathew MS, Olaniran M, Messiah SE, Almandoz JP.   +9 more
europepmc   +1 more source

RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide. [PDF]

J Endocrinol
Mashayekhi M, Safa BI, Nian H, Devin JK, Gamboa JL, Yu C, Chen R, Beckman JA, Koethe JR, Silver HJ, Niswender K, Luther JM, Brown NJ.   +12 more
europepmc   +1 more source

Critical Evaluation of "GLP-1 and Dual GLP-1/GIP Receptor Agonists in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis". [PDF]

Clin Cardiol
Bibi Z.
europepmc   +1 more source